A Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With Schizophrenia

A Retrospective, Non-interventional Study to Evaluate the Use of Seroquel XR and Seroquel IR in the Clinical Practice of Inpatients With Schizophrenia

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01214135

Acronym

SPIN

Enrollment

300

Registered

2010-10-04

Start date

2010-10-31

Completion date

2010-12-31

Last updated

2011-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Keywords

Mental disorder, antipsychotic treatment

Brief summary

The primary objective of this non-interventional study is to investigate how Seroquel XR and Seroquel IR are used in the clinical practice of inpatients with schizophrenia. This will be done by a retrospective review of medical records to evaluate patients treated with Seroquel XR or Seroquel IR as primary antipsychotic treatment.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Diagnosis of schizophrenia. * At least one dose of Seroquel XR or Seroquel IR during the study period (1st of July 2009 - 30th of September 2010). * Hospitalization due to psychotic symptoms at any time during the study period (1st of July 2009 - 30th of September 2010) and with admission and discharge dates available.

Exclusion criteria

* Participation in a clinical trial during the study period. * Treatment in forensic care according to LRV (Lagen om Rättspsykiatrisk Vård).

Design outcomes

Primary

Measure	Time frame
To investigate how Seroquel XR and Seroquel IR are used in the clinical practice of inpatients with schizophrenia	every day for the time period of 15 Oct to 31 Dec 2010

Secondary

Measure	Time frame
To investigate comorbidities of patients with schizophrenia receiving Seroquel XR and IR	every day for the time period of 15 Oct to 31 Dec 2010
To investigate whether Seroquel XR and Seroquel IR are used to treat different types of inpatients with schizophrenia by evaluation of patient characteristics	every day for the time period of 15 Oct to 31 Dec 2010
To investigate the treatment sequence of Seroquel XR and Seroquel IR in the clinical practice of patients with schizophrenia by evaluation of duration, dosage, reason for treatment, and, if applicable, reason for change, with Seroquel XR and Seroquel IR	every day for the time period of 15 Oct to 31 Dec 2010

Countries

Sweden

Outcome results